期刊文献+

CPAP治疗OSAHS伴动脉粥样硬化患者对动脉粥样硬化的稳定作用 被引量:1

CPAP for the Treatment of OSAHS with Stable Effect on Atherosclerosis in Patients with Atherosclerosis
下载PDF
导出
摘要 目的探讨持续气道正压通气(CPAP)治疗阻塞性睡眠呼吸暂停低通气综合征(OSAHS)伴动脉粥样硬化患者对动脉粥样硬化的稳定作用。方法 OSAHS患者64例行无创正压呼吸机治疗3个月,检测治疗前、后多导睡眠监测、白细胞介素-6(IL-6)、C反应蛋白水平(CRP)及颈动脉内膜中层厚度(IMT)。结果呼吸机治疗后白细胞介素-6、C反应蛋白水平、颈动脉内膜中层厚度及呼吸暂停指数(AHI)均下降,与治疗前比较差异有统计学意义(P<0.05);最低血氧饱和度(Sp O2)较治疗前升高(P<0.05)。结论 CPAP治疗可能通过降低OSAHS患者血清CRP水平、IL-6,抑制OSAHS患者炎性反应,因而降低OSAHS患者动脉粥样硬化的进程以及心脑血管疾病的发生率。 Objective To investigate continuous positive airway pressure (CPAP) in treatment of obstructive sleep apnea hypopnea syndrome associated with atherosclerosis in patients with stable effect on atherosclerosis. Methods OSAHS in 64 patients with noninvasive positive pressure ventilation in the treatment of 3 months, detected before and after treatment, polysomnography, interleuldn-6 (IL-6), C reactive protein (CRP) and carotid artery intima-media thickness (IMT). Result After ventilator treatment interleukin-6, C-reactive protein levels, carotid intima-media thickness and apnea hypopnea index (AHI) were decreased, compared with that before treatment (P〈0.05) statistical significance; the lowest oxygen saturation (SpO2) compared with those before treatment (P〈0.05) increased. Conclusion CPAP treatment could decrease the level of serum CRP in patients with OSAHS, IL-6, inhibit inflammatory reaction in patients with OSAHS, and thus reduce the incidence of atherosclerosis in patients with OSAHS process and cardiovascular and cerebrovascular diseases.
出处 《中国医药指南》 2015年第12期4-4,共1页 Guide of China Medicine
关键词 持续气道正压通气 阻塞性睡眠呼吸暂停低通气综合征 动脉粥样硬化 Continuous positive airway pressure Obstructive sleep apnea-hypopnea syndrome Atherosclerosis
  • 相关文献

参考文献3

二级参考文献18

  • 1Fandrey J, Seydel FP, Siegers CP, et al. Role of cyto-chrome P450 in the control of the production of erythropoietin [J]. Life Sci, 1990, 47: 127-134.
  • 2Acker H. Cellular oxygen sensors[J]. Ann NY Acad Sci, 1994,718: 3-10.
  • 3Duranteau J, Chandel NS, Kuliscz A, et al. Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes[J]. J Biol Chem, 273, 1998, 11619-11624.
  • 4Chandel, NS, Maltepe, E, Goldwasser, E, et al. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription [J].Proc Natl Acad Sci USA, 1999, 95: 11715-11720.
  • 5Fandrey, J, Genius, J. Reactive oxygen species as regulators of oxygen dependent gene expression[J]. Adv Exp Med Biol, 2000,475: 153-159.
  • 6Chakraborti Das S, Mondal M, Roychoudhury S, Chakraborti S.Oxidants mitochondria and calcium: an overview[J]. Cell Signal,1999, 11: 77-85.
  • 7Carl Nathan. Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling [J]. J Clin Invest, 2003,111: 769-778.
  • 8CHUANYU LI AND ROBERT M. JACKSON Reactive species mechanisms of cellular hypoxiareoxygenation injury [J]. Am J Physiol Cell Physiol, 2002, 282: 227-241.
  • 9Yin, T, Sandhu, G, Wol fgang, C D, et al. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney[J]. J Biol Chem, 1997, 272: 19943-19950.
  • 10Katrina Mackay and Daria Moohly-Rosen,An Inhibitor of p38Mitogen-activated Protein Kinase Protects Neonatal Cardiac Myocytes from Ischemia[J]. J Biol Chem, 1999, 274: 6272-6279.

共引文献327

同被引文献10

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部